LEVODOPA - PHARMACOLOGY, PHARMACOKINETICS, AND PHARMACODYNAMICS

被引:35
作者
JUNCOS, JL [1 ]
机构
[1] EMORY UNIV, SCH MED, MOVEMENT DISORDERS PROGRAM, ATLANTA, GA 30322 USA
关键词
D O I
10.1016/S0733-8619(18)30223-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:487 / 509
页数:23
相关论文
共 50 条
[11]   The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease [J].
Khor, Soo-Peang ;
Hsu, Ann .
CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (03) :234-243
[12]   Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients [J].
Triggs, EJ ;
Charles, BG ;
Contin, M ;
Martinelli, P ;
Cortelli, P ;
Riva, R ;
Albani, F ;
Baruzzi, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) :59-67
[13]   LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS [J].
NUTT, JG ;
WOODWARD, WR .
NEUROLOGY, 1986, 36 (06) :739-744
[15]   OXPRENOLOL - CLINICAL-PHARMACOLOGY, PHARMACOKINETICS, AND PHARMACODYNAMICS [J].
KENDALL, MJ ;
JOHN, VA .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (09) :D27-D33
[16]   Polymyxins: Pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications [J].
Hermsen, ED ;
Sullivan, CJ ;
Rotschafer, JC .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) :545-+
[17]   Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson's disease [J].
Mueller, Thomas .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (05) :403-414
[19]   CRATAEGUS, TOXICOLOGY AND PHARMACOLOGY .3. PHARMACODYNAMICS AND PHARMACOKINETICS [J].
AMMON, HPT ;
HANDEL, M .
PLANTA MEDICA, 1981, 43 (04) :313-322
[20]   PHARMACOLOGY, PHARMACODYNAMICS AND PHARMACOKINETICS OF SOTALOL - DISCUSSION .1. [J].
SINGH, B ;
ANTONACCIO, M ;
SOYKA, L ;
SAMI, M ;
REIFFEL, J ;
LATHROP, D ;
WOOSLEY, R ;
MAHMARIAN, J ;
DEEDWANIA, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (02) :A35-A36